Iefile GRAPHIC print - DO NOT PROCESS I As Filed Data - l DLN193493316047725I Form990 Return of Organization Exempt From Income Tax OMB No 1545-0047 E Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except private 20 1 4 foundations) Department of the Treasury h- Do not enter SOCIal security numbers on this form as it may be made public Open to Public Internal Revenue Sewice h-Information about Form 990 and its instructions is at www.IRS.gov[form990 Inspection A For the 2014 calendar year, or tax year beginning 01-01-2014 , and ending 12-31-2014 C Name of organization B Check if applicable D Employer identification number PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA '- Address change 53-0241211 I- Name change D0ing busmess as PHRMA '- Initial return E Telephone number Final Number and street (or P 0 box if mail is not delivered to street address) Room/smte 950 F STREET NO 300 '- return/term inated (202)835-3400 '- Amended return City or town, state or provmce, country, and ZIP or foreign postal code WASHINGTON, DC 20004 G Gross receipts $ 208,707,137 '- Application pending F Name and address of prinCIpal officer H(a) Is this a group return for STEPHEN J UBL subordinates? I-YesI7No 950 F STREET NO 300 WASHINGTON,DC 20004 H(b) Are all subordinates I- Yes I- No included? I Tax-exem pt status I- 501(c)(3) l7 501(c)(6) 1 (insert no) I- 4947(a)(1) or I- 527 If"No," attach a list (see instructions) J Websitei II- WWW PHRMA 0 RG H(c) Group exemption number k- K Form of organization '7 Corporation '- Trust '- Assoaation '- Other I'- L Year of formation 1958 M State of legal domICIle DE m Summary 1 Briefly describe the organization's missmn or most Significant actiVities PHRMA'S MISSION IS WINNING ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE THE DISCOVERY OF LIFE- SAVING AND LIFE-ENHANCING NEW MEDICINES FOR PATIENTS BY PHARMACEUTICAL/BIOTECHNOLOGY RESEARCH q. COMPANIES g E E E 2 Check this box h1- ifthe organization discontinued its operations or disposed of more than 25% ofits net assets 36 $- 3 Number ofvoting members ofthe governing body (Part VI, line 1a) 3 32 E 4 Number ofindependent voting members ofthe governing body (Part VI, line 1b) . 4 31 E 5 Total number ofindiViduals employed in calendar year 2014 (Part V, line 2a) 5 227 d; 6 Total number ofvolunteers (estimate if necessary) 6 2,891 7aTotal unrelated busmess revenue from Part VIII, column (C), line 12 7a 0 b Net unrelated busmess taxable income from Form 990-T, line 34 7b 0 Prior Year Current Year 8 Contributions and grants (Part VIII, line 1h) 0 0 cu E 9 Program serVIce revenue (PartVIII,line 29) 202,890,617 205,359,701 E 10 Investmentincome(PartVIII,column(A),lines 3,4,and 7d) 1,800,589 3,258,755 ii 11 Otherrevenue(PartVIII,column(A),lines 5,6d,8c,9c,10c,and11e) 20,780 33,650 12 Total revenue-add lines 8 through 11 (must equal Part VIII, column (A), line 12) I I I I I I I I I 204,711,986 208,652,106 13 Grants and Similaramounts paid (PartIX,column(A),lines 1-3) 16,065,665 20,773,061 14 Benefits paid to orfor members (PartIX,column (A),line 4) O 0 g 15 gallagifs,othercompensation,employee benefits (PartIX,column (A),lines 53,357,187 49,391,451 E 16a Professmnalfundraismg fees (PartIX,column(A),line 11e) O O E b Total fundraismg expenses (Part D(, column (D), line 25) F0 17 Otherexpenses(PartIX,column(A),lines11a-11d,11f-24e) 132,706,908 137,777,125 18 Totalexpenses Add lines 13-17 (must equalPartIX,column (A),line 25) 202,129,760 207,941,637 19 Revenue less expenses Subtract line 18 from line 12 2,582,226 710,469 3 E Beginning of Current End of Year 3.3% Year q- 32 20 Totalassets (PartX,line 16) 130,160,555 135,545,781 5'3 21 Totalliabilities (Part X,line 26) 46,428,561 93,194,442 in ZI-I- 22 Net assets orfund balances Subtract line 21 from line 20 83,731,994 42,351,339 Signature Block Under penalties of perjury, I declare thatI have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge N ****** l2015-11-12 Sign Signature of officer Date Here STEPHEN J UBL PRESIDENT & CEO Type or print name and title Print/Type preparer's name Preparefs Signature Date Check '- if PTIN P Id DEBORAH G KOSNETI' DEBORAH G KOSNETI' 2015-11-11 self-employed P00290720 al Firm's name P- TATE AND TRYON Firm's EIN P- 52-1855942 Preparer Use Only Finn's address F2021 L STREET NW SUITE 400 Phone no (202) 293-2200 WASHINGTON, DC 20036 May the IRS discuss this return With the preparer shown above? (see instructions) . I7Yes I-No For Paperwork Reduction Act Notice, see the separate instructions. Cat No 1 1 282Y Form 990 (20 14) Form 990 (2014) Page2 m Statement of Program Service Accomplishments CheckifScheduleOcontainsaresponseornotetoanylineinthisPartIII . .I- 1 Briefly describe the organization's missmn PHRMA'S MISSION IS WINNING ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE THE DISCOVERY OF LIFE-SAVING AND LIFE-ENHANCING NEW MEDICINES FOR PATIENTS BY PHARMACEUTICAL/BIOTECHNOLOGY RESEARCH COMPANIES 2 Did the organization undertake any Significant program serVIces during the year which were not listed on thepriorForm990 or990-EZ? . I-Yes I7No If"Yes," describe these new serVIces on Schedule 0 3 Did the organization cease conducting, or make Significant changes in how it conducts, any program serwces'P............................ I-Yesl7No If"Yes," describe these changes on Schedule 0 4 Describe the organization's program serVIce accomplishments for each ofits three largest program serVIces, as measured by expenses Section 501(c)(3) and 501(c)(4) organizations are reqUIred to report the amount ofgrants and allocations to others, the total expenses, and revenue, ifany, for each program serVIce reported 4a (Code ) (Expenses $ including grants of $ ) (Revenue $ ) PUBLIC POLICY ADVOCACY PHRMA'S MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE DISCOVERY OF IMPORTANT NEW MEDICINES FOR PATIENTS BY PHARMACEUTICAL/BIOTECHNOLOGY RESEARCH COMPANIES PHRMA ACHIEVES THIS MISSION BY WORKING WITH, AND ON BEHALF OF, ITS MEMBER COMPANIES BEFORE GOVERNMENTAL AND REGULATORY BODIES IN THE UNITED STATES AND THROUGHOUT THE WORLD IN SUPPORT OF PRO- PATIENT, PRO-INNOVATION POLICIES SPECIFICALLY, PHRMA ADVOCATES FOR BROAD PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICINES THROUGH A FREE MARKET, WITHOUT GOVERNMENT PRICE CONTROLS, STRONG INTELLECTUAL PROPERTY INCENTIVES, AND TRANSPARENT, EFFICIENT REGULATION AND A FREE FLOW OF INFORMATION TO PATIENTS 4b (Code ) (Expenses $ including grants of $ ) (Revenue $ ) MEMBER SERVICES IN REPRESENTING THE COUNTRY'S LEADING PHARMACEUTICAL RESEARCH AND BIOTECHNOLOGY COMPANIES, PHRMA PROVIDES A FORUM FOR MEMBER COMPANIES TO PARTICIPATE IN DISCUSSIONS OF RELEVANT HEALTH CARE ISSUES AND TO DEVELOP CONSENSUS POSITIONS ON MATTERS OF PUBLIC POLICY ADVOCACY MEMBER COMPANIES PARTICIPATE IN PHRMA ACTIVITIES THROUGH REPRESENTATION ON THE BOARD OF DIRECTORS, BOARD-LEVEL COMMITTEES AND KEY ISSUE TEAMS, STAFF WORK GROUPS, SECTIONS, TASK FORCES, AND SUBCOMMITI'EES MEMBER COMPANY REPRESENTATIVES ALSO REGULARLY COMMUNICATE WITH PHRMA STAFF 4c (Code ) (Expenses $ including grants of $ ) (Revenue $ ) GENERAL EDUCATION ABOUT BIOPHARMACEUTICAL INDUSTRY PHRMA DISSEMINATES INFORMATION ABOUT BIOPHARMACEUTICAL COMPANIES, THEIR PRODUCTS, AND THEIR BUSINESS, SCIENTIFIC AND PHILANTHROPIC ACTIVITIES THROUGH A WIDE RANGE OF CHANNELS, INCLUDING PROFILES, REPORTS, PRINCIPLES, GUIDELINES, FACT SHEETS, POLICY PAPERS AND OTHER RESOURCES THESE EFFORTS BOLSTER PHRMA'S ABILITY TO EDUCATE AND INFORM MEMBERS OF THE GENERAL PUBLIC AS WELL AS POLICYMAKERS, THE MEDIA, PATIENTS AND OTHERS IN THE HEALTH CARE COMMUNITY ABOUT THE BIOPHARMACEUTICAL INDUSTRY AND PHRMA'S PUBLIC POLICY ACTIVITIES IN PARTICULAR 4d Other program serVIces (Describe in Schedule 0 ) (Expenses $ including grants of$ ) (Revenue $ ) 4e Total program service expenses h- Form 990(2014) Form 990 (2014) Page 3 Checklist of Required Schedules Yes No Is the organization described in section 501(c)(3) or 4947(a)(1) (otherthan a private foundation)? If "Yes," No comp/eteSchedu/eA 1 Is the organization reqUIred to complete Schedule B, Schedule of Contributors (see instructions)? 2 No Did the organization engage in direct or indirect political campaign actiVities on behalf ofor in oppOSition to Yes candidates for public office? If "Yes,"complete Schedule C, Part I 3 Section 501(c)(3) organizations. Did the organization engage in lobbying actiVities, or have a section 501(h) election in effect during the tax year? If "Yes,"complete Schedule C, Part II 4 Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or Similar amounts as defined in Revenue Procedure 98-19? If "Yes,"complete Schedule C, 5 YeS Part HIE Did the organization maintain any donor adVIsed funds or any SimilarfundS or accounts for which donors have the right to prOVIde adVIce on the distribution or investment ofamounts in such funds or accounts? If "Yes," complete No Schedule D, Part I 6 Did the organization receive or hold a conservation easement, including easements to preserve open space, the enVIronment, historic land areas, or historic structures? If "Yes,"complete Schedule D, Part II 7 No Did the organization maintain collections of works ofart, historical treasures, or other Similar assets? If "Yes," complete Schedule D, Part III E 8 No Did the organization report an amount in Part